- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
- ↑ Teegarden, B. R.; Li, H.; Jayakumar, H.; Strah-Pleynet, S.; Dosa, P. I.; Selaya, S. D.; Kato, N.; Elwell, K. H. i dr.. (2010). „Discovery of 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (Nelotanserin) and Related 5-Hydroxytryptamine2AInverse Agonists for the Treatment of Insomnia”. Journal of Medicinal Chemistry 53 (5): 1923. DOI:10.1021/jm9007328. PMID 20143782.
- ↑ Rosenberg, R; Seiden, DJ; Hull, SG; Erman, M; Schwartz, H; Anderson, C; Prosser, W; Shanahan, W i dr.. (2008). „APD125, a selective serotonin 5-HT2A receptor inverse agonist, significantly improves sleep maintenance in primary insomnia”. Sleep 31 (12): 1663–71. PMC 2603489. PMID 19090322.
- ↑ Al-Shamma, H. A.; Anderson, C.; Chuang, E.; Luthringer, R.; Grottick, A. J.; Hauser, E.; Morgan, M.; Shanahan, W. i dr.. (2009). „Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia”. Journal of Pharmacology and Experimental Therapeutics 332 (1): 281. DOI:10.1124/jpet.109.160994. PMID 19841476.
- ↑ „APD125 for Insomnia”. Arhivirano iz originala na datum 2009-08-26. Pristupljeno 2014-04-05.
- ↑ Xiong, Y.; Ullman, B.; Choi, J. S. K.; Cherrier, M.; Strah-Pleynet, S.; Decaire, M.; Dosa, P. I.; Feichtinger, K. i dr.. (2010). „Synthesis and in Vivo Evaluation of Phenethylpiperazine Amides: Selective 5-Hydroxytryptamine2A Receptor Antagonists for the Treatment of Insomnia”. Journal of Medicinal Chemistry 53 (15): 5696. DOI:10.1021/jm100479q. PMID 20684606.
Spoljašnje veze
uredi